Información del producto
BMS 688521 is a fluorinated monoclonal antibody that binds to the target protein, which is expressed in inflammatory bowel disease and cancer. It has been shown to stabilize the supramolecular structure of the molecule and inhibit its degradation. The drug targets the microenvironment of the tumor to help deliver chemotherapy drugs to the tumor cells. BMS 688521 is also effective in treating bowel disease by inhibiting inflammation caused by pro-inflammatory cytokines. This drug has been shown to be safe for use in humans in clinical studies with few side effects.
Propiedades químicas
Consulta técnica sobre: 3D-TKB39744 BMS 688521
Si desea solicitar un presupuesto o realizar un pedido, por favor añada los productos deseados a su carrito y solicite un presupuesto o pedido desde el carrito. Es más rápido, más barato, y podrá beneficiarse de los descuentos y las ventajas disponibles.